Orforglipron (LY-3502970) Lyophilized Powder for Weight Loss Research | CAS 2212020-52-3

Orforglipron (LY-3502970) is a novel GLP-1 receptor agonist currently being investigated for its potential in weight management and metabolic regulation. This lyophilized powder form offers researchers a stable and convenient format for scientific studies.

As a GLP-1 receptor agonist, Orforglipron works through multiple mechanisms to potentially support weight management. These include slowing gastric emptying, reducing appetite, and improving glucose metabolism. The compound has shown promise in preclinical studies for its effects on metabolic parameters.

The lyophilized powder format ensures stability and long shelf life when stored properly. Researchers can easily reconstitute the powder for various experimental applications in metabolic research.

Key Research Applications:

1. Investigation of GLP-1 receptor activation pathways

2. Metabolic syndrome and obesity research

3. Glucose homeostasis studies

4. Appetite regulation mechanisms

5. Comparative studies with other GLP-1 agonists

6. Long-term metabolic effects research

This product is intended for research purposes only and not for human consumption. Proper laboratory safety protocols should always be followed when handling this material.